Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-28
2000-02-29
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514359, 514211, 514212, 514288, 514411, 540597, A61K 3144, A61K 3155, A61K 3138, A61K 3140, C07D40100
Patent
active
060309849
ABSTRACT:
The invention is concerned with the use of bi- and tricyclic pyridone compounds of the formula where A, R.sup.1, R.sup.3, R.sup.4, and R.sup.7 are described herein and of their pharmaceutically acceptable salts for the production of medicaments for the prophylaxis or treatment of illnesses which are connected with an inhibition of .beta.-amyloid peptide activity, especially for the treatment of Alzheimer's disease.
REFERENCES:
patent: 4735940 (1988-04-01), Fischer et al.
patent: 4889848 (1989-12-01), Fischer et al.
patent: 5036066 (1991-07-01), Fischer et al.
patent: 5321021 (1994-06-01), Fischer et al.
patent: 5707651 (1998-01-01), Becourt et al.
Derwent Abstract. Hata T., et al., Agent to treat conjunctivitis, chronic rheumatoid arthritis, etc.--contains quinolidinone derivative especially N-(5-(1H-tetrazolyl))-1-phenoxy-4H-quinolidine-4-one 3-carboxamide.
Imai, T., et al., Effects of a novel orally-active antiallergic drug, quinotolast (FK021), on airway clearance. 1994, Folia Pharmacol. Jpn, 104, 347-355.
Griebel, G., et al., Further Evidence for Differences Between Non-Selective and BZ-1 ( -1) Selective, Benzodiazepine Receptor Ligands in Murine Models of "State" and "Trait" Anxiety, 1996, Neuropharmacology, vol. 35, No. 8, 1081-1091.
Jakob-Roetne Roland
Kolczewski Sabine
Norcross Roger David
Trottmann Gerda Huber
Woltering Thomas Johannes
Criares Theodore J.
Ebel Eileen M.
Hoffmann-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
LandOfFree
Pyridone compounds useful in treating Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridone compounds useful in treating Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridone compounds useful in treating Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-683358